Anti-Oxidant Treatment of Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
ADNI: Alzheimer's Disease Neuroimaging Initiative
- Status
- COMPLETED
- Phase
- N/A
Memory Aid for Informed Consent in Alzheimer's Research
- Status
- COMPLETED
- Phase
- NA
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Curcumin in Patients With Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
- Status
- COMPLETED
- Phase
- PHASE3
Biomarkers and Early Alzheimer's Disease
- Status
- UNKNOWN
- Phase
- N/A
SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)
- Status
- COMPLETED
- Phase
- PHASE2
Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2